Qu Deng

821 total citations
8 papers, 454 citations indexed

About

Qu Deng is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Qu Deng has authored 8 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in Qu Deng's work include Cancer Genomics and Diagnostics (3 papers), Prostate Cancer Treatment and Research (3 papers) and PARP inhibition in cancer therapy (2 papers). Qu Deng is often cited by papers focused on Cancer Genomics and Diagnostics (3 papers), Prostate Cancer Treatment and Research (3 papers) and PARP inhibition in cancer therapy (2 papers). Qu Deng collaborates with scholars based in United States, China and Germany. Qu Deng's co-authors include Dean G. Tang, Irfan A. Asangani, Reyaz ur Rasool, Ramakrishnan Natesan, Hsueh‐Ping Chao, Jianjun Shen, Kiera Rycaj, Dingxiao Zhang, Can Liu and Yue Lu and has published in prestigious journals such as Nature Communications, Cell Reports and Cancer Discovery.

In The Last Decade

Qu Deng

8 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qu Deng United States	6	261	172	146	133	44	8	454
Elizabeth K. Lee United States	13	205 0.8×	59 0.3×	153 1.0×	309 2.3×	22 0.5×	34	662
Nur Rahadiani Indonesia	9	169 0.6×	127 0.7×	27 0.2×	214 1.6×	27 0.6×	42	414
Xinquan Gu China	9	223 0.9×	141 0.8×	63 0.4×	68 0.5×	11 0.3×	19	417
Giulia Scotto Italy	10	177 0.7×	99 0.6×	106 0.7×	242 1.8×	5 0.1×	19	458
Vittoria Castiglioni Italy	10	174 0.7×	39 0.2×	69 0.5×	82 0.6×	43 1.0×	15	363
Xiaoxiao Yao China	8	316 1.2×	295 1.7×	66 0.5×	81 0.6×	7 0.2×	11	471
Takeshi Hirao Japan	13	248 1.0×	68 0.4×	175 1.2×	126 0.9×	5 0.1×	23	534
Chaoxi Zhou China	10	188 0.7×	122 0.7×	44 0.3×	80 0.6×	10 0.2×	32	318
Takuhei Yokoyama Japan	11	174 0.7×	63 0.4×	31 0.2×	117 0.9×	13 0.3×	17	399

Countries citing papers authored by Qu Deng

Since Specialization

Citations

This map shows the geographic impact of Qu Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qu Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qu Deng more than expected).

Fields of papers citing papers by Qu Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qu Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qu Deng. The network helps show where Qu Deng may publish in the future.

Co-authorship network of co-authors of Qu Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Qu Deng. A scholar is included among the top collaborators of Qu Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qu Deng. Qu Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Deng, Qu, Ramakrishnan Natesan, Florencia Cidre‐Aranaz, et al.. (2022). Oncofusion-driven de novo enhancer assembly promotes malignancy in Ewing sarcoma via aberrant expression of the stereociliary protein LOXHD1. Cell Reports. 39(11). 110971–110971. 8 indexed citations

2.

Deng, Qu, Reyaz ur Rasool, Ronnie M. Russell, Ramakrishnan Natesan, & Irfan A. Asangani. (2021). Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19. iScience. 24(3). 102254–102254. 65 indexed citations

3.

Deng, Qu, et al.. (2021). Impact of Online Claims for Investor Protection on Enterprise Capital Structures: Evidence from Big Data in China. Procedia Computer Science. 187. 183–187. 1 indexed citations

4.

Deng, Qu, Reyaz ur Rasool, Ronnie M. Russell, Ramakrishnan Natesan, & Irfan A. Asangani. (2020). Targeting Androgen Regulation of TMPRSS2 and ACE2 as a Therapeutic Strategy to Combat COVID-19. SSRN Electronic Journal. 1 indexed citations

5.

Rasool, Reyaz ur, Ramakrishnan Natesan, Qu Deng, et al.. (2019). CDK7 Inhibition Suppresses Castration-Resistant Prostate Cancer through MED1 Inactivation. Cancer Discovery. 9(11). 1538–1555. 86 indexed citations

6.

Liu, Can, Ruifang Liu, Dingxiao Zhang, et al.. (2017). MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes. Nature Communications. 8(1). 14270–14270. 186 indexed citations

7.

Deng, Qu & Dean G. Tang. (2015). Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications. Endocrine Related Cancer. 22(6). T209–T220. 49 indexed citations

8.

Liu, Xin, Xin Chen, Kiera Rycaj, et al.. (2015). Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells. Oncotarget. 6(27). 23959–23986. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact